Survival analysis on the institutional dataset revealed that the low expression of DNASE1L3 in tumor tissue is correlated with a significantly decreased disease‐free survival (DFS) (Log‐rank p = 0.0037) and overall survival (OS) (Log‐rank p = 0.0009) of the patients, as depicted in Figure 7f. This evidence concerns the gene DNASE1L3 and neoplasm.